메뉴 건너뛰기




Volumn 9, Issue 3, 2017, Pages 256-266

Recent trends in the use of antidiabetic medications from 2008 to 2013: A nation-wide population-based study from Taiwan

Author keywords

antidiabetic drug; Chinese; dipeptidyl peptidase 4 inhibitors; type 2 diabetes

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; BIGUANIDE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; EXENDIN 4; GLITAZONE DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; INSULIN; LIRAGLUTIDE; METFORMIN; NATEGLINIDE; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SAXAGLIPTIN; SITAGLIPTIN; SULFONYLUREA; VILDAGLIPTIN; GLUCOSE BLOOD LEVEL; SULFONYLUREA DERIVATIVE;

EID: 84971386837     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12408     Document Type: Article
Times cited : (25)

References (33)
  • 1
    • 38149142887 scopus 로고    scopus 로고
    • Available from, accessed 8 April 2016.
    • World Health Organization (WHO). Diabetes fact sheet. 2016. Available from: http://www.who.int/mediacentre/factsheets/fs312/en/, accessed 8 April 2016.
    • (2016) Diabetes fact sheet
  • 2
    • 84856740961 scopus 로고    scopus 로고
    • Oral pharmacologic treatment of type 2 diabetes mellitus: A clinical practice guideline from the American College of Physicians
    • Qaseem A, Humphrey LL, Sweet DE, Starkey M, Shekelle P, Clinical Guidelines Committee of the American College of Physicians. Oral pharmacologic treatment of type 2 diabetes mellitus: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine. 2012; 156: 218–231.
    • (2012) Annals of Internal Medicine , vol.156 , pp. 218-231
    • Qaseem, A.1    Humphrey, L.L.2    Sweet, D.E.3    Starkey, M.4    Shekelle, P.5
  • 3
    • 84922059441 scopus 로고    scopus 로고
    • Trend and factors associated with healthcare use and costs in type 2 diabetes mellitus: A decade experience of a universal health insurance program
    • Cheng JS, Tsai WC, Lin CL et al. Trend and factors associated with healthcare use and costs in type 2 diabetes mellitus: A decade experience of a universal health insurance program. Medical Care. 2015; 53: 116–124.
    • (2015) Medical Care , vol.53 , pp. 116-124
    • Cheng, J.S.1    Tsai, W.C.2    Lin, C.L.3
  • 4
    • 84968822322 scopus 로고    scopus 로고
    • 6th, edn., Brussels, IDF
    • International Diabetes Federation (IDF). IDF Diabetes Atlas, 6th edn. Brussels, IDF, 2013.
    • (2013) IDF Diabetes Atlas
  • 6
    • 79953117559 scopus 로고    scopus 로고
    • The determinants of the adoption of pharmaceutical innovation: Evidence from Taiwan
    • Liu YM, Yang YH, Hsieh CR. The determinants of the adoption of pharmaceutical innovation: Evidence from Taiwan. Social Science & Medicine. 2011; 72: 919–927.
    • (2011) Social Science & Medicine , vol.72 , pp. 919-927
    • Liu, Y.M.1    Yang, Y.H.2    Hsieh, C.R.3
  • 8
    • 79960557423 scopus 로고    scopus 로고
    • Trends in drug prescriptions to diabetic patients from 2000 to 2008 in Italy's Lombardy Region: A large population-based study
    • Baviera M, Monesi L, Marzona I et al. Trends in drug prescriptions to diabetic patients from 2000 to 2008 in Italy's Lombardy Region: A large population-based study. Diabetes Research and Clinical Practice. 2011; 93: 123–130.
    • (2011) Diabetes Research and Clinical Practice , vol.93 , pp. 123-130
    • Baviera, M.1    Monesi, L.2    Marzona, I.3
  • 9
    • 0042168933 scopus 로고    scopus 로고
    • Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes
    • Cohen FJ, Neslusan CA, Conklin JE, Song X. Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes. Diabetes Care. 2003; 26: 1847–1851.
    • (2003) Diabetes Care , vol.26 , pp. 1847-1851
    • Cohen, F.J.1    Neslusan, C.A.2    Conklin, J.E.3    Song, X.4
  • 10
    • 70450199786 scopus 로고    scopus 로고
    • Trends in the prescription of anti-diabetic medications in the United Kingdom: A population-based analysis
    • Filion KB, Joseph L, Boivin JF, Suissa S, Brophy JM. Trends in the prescription of anti-diabetic medications in the United Kingdom: A population-based analysis. Pharmacoepidemiology and Drug Safety. 2009; 18: 973–976.
    • (2009) Pharmacoepidemiology and Drug Safety , vol.18 , pp. 973-976
    • Filion, K.B.1    Joseph, L.2    Boivin, J.F.3    Suissa, S.4    Brophy, J.M.5
  • 11
    • 84875911172 scopus 로고    scopus 로고
    • Trends in antidiabetic prescription patterns in Japan from 2005 to 2011
    • Kohro T, Yamazaki T, Sato H et al. Trends in antidiabetic prescription patterns in Japan from 2005 to 2011. International Heart Journal. 2013; 54: 93–97.
    • (2013) International Heart Journal , vol.54 , pp. 93-97
    • Kohro, T.1    Yamazaki, T.2    Sato, H.3
  • 13
    • 70350051492 scopus 로고    scopus 로고
    • Trends in medication use among US adults with diabetes mellitus: Glycemic control at the expense of controlling cardiovascular risk factors
    • Mann DM, Woodward M, Ye F, Krousel-Wood M, Muntner P. Trends in medication use among US adults with diabetes mellitus: Glycemic control at the expense of controlling cardiovascular risk factors. Archives of Internal Medicine. 2009; 169: 1718–1720.
    • (2009) Archives of Internal Medicine , vol.169 , pp. 1718-1720
    • Mann, D.M.1    Woodward, M.2    Ye, F.3    Krousel-Wood, M.4    Muntner, P.5
  • 14
    • 44549084246 scopus 로고    scopus 로고
    • Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: A 4-year retrospective study from national primary care data
    • Mazzaglia G, Yurgin N, Boye KS et al. Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: A 4-year retrospective study from national primary care data. Pharmacological Research. 2008; 57: 358–363.
    • (2008) Pharmacological Research , vol.57 , pp. 358-363
    • Mazzaglia, G.1    Yurgin, N.2    Boye, K.S.3
  • 15
    • 33746778857 scopus 로고    scopus 로고
    • Utilisation of antihyperglycaemic drugs in ten European countries: Different developments and different levels
    • Melander A, Folino-Gallo P, Walley T et al. Utilisation of antihyperglycaemic drugs in ten European countries: Different developments and different levels. Diabetologia. 2006; 49: 2024–2029.
    • (2006) Diabetologia , vol.49 , pp. 2024-2029
    • Melander, A.1    Folino-Gallo, P.2    Walley, T.3
  • 16
    • 84926217982 scopus 로고    scopus 로고
    • Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of southern Italy: A population-based study
    • Rafaniello C, Arcoraci V, Ferrajolo C et al. Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of southern Italy: A population-based study. Diabetes Research and Clinical Practice. 2015; 108: 157–163.
    • (2015) Diabetes Research and Clinical Practice , vol.108 , pp. 157-163
    • Rafaniello, C.1    Arcoraci, V.2    Ferrajolo, C.3
  • 17
    • 28044450154 scopus 로고    scopus 로고
    • Trends and influences on use of antidiabetic drugs in England, 1992–2003
    • Walley T, Hughes D, Kendall H. Trends and influences on use of antidiabetic drugs in England, 1992–2003. Pharmacoepidemiology and Drug Safety. 2005; 14: 769–773.
    • (2005) Pharmacoepidemiology and Drug Safety , vol.14 , pp. 769-773
    • Walley, T.1    Hughes, D.2    Kendall, H.3
  • 18
    • 0041668076 scopus 로고    scopus 로고
    • Rapid increase in the use of oral antidiabetic drugs in the United States, 1990–2001
    • Wysowski DK, Armstrong G, Governale L. Rapid increase in the use of oral antidiabetic drugs in the United States, 1990–2001. Diabetes Care. 2003; 26: 1852–1855.
    • (2003) Diabetes Care , vol.26 , pp. 1852-1855
    • Wysowski, D.K.1    Armstrong, G.2    Governale, L.3
  • 20
    • 33745290289 scopus 로고    scopus 로고
    • The 30-year natural history of type 1 diabetes complications: The Pittsburgh Epidemiology of Diabetes Complications Study experience
    • Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ. The 30-year natural history of type 1 diabetes complications: The Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes. 2006; 55: 1463–1469.
    • (2006) Diabetes , vol.55 , pp. 1463-1469
    • Pambianco, G.1    Costacou, T.2    Ellis, D.3    Becker, D.J.4    Klein, R.5    Orchard, T.J.6
  • 21
    • 67749084303 scopus 로고    scopus 로고
    • Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications experience (1983–2005)
    • Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications experience (1983–2005). Archives of Internal Medicine. 2009; 169: 1307–1316.
    • (2009) Archives of Internal Medicine , vol.169 , pp. 1307-1316
  • 23
    • 33845501459 scopus 로고    scopus 로고
    • Age and sex may significantly interact with diabetes on the risks of lower-extremity amputation and peripheral revascularization procedures: Evidence from a cohort of a half-million diabetic patients
    • Chen H-F, Ho C-A, Li C-Y. Age and sex may significantly interact with diabetes on the risks of lower-extremity amputation and peripheral revascularization procedures: Evidence from a cohort of a half-million diabetic patients. Diabetes Care. 2006; 29: 2409–2414.
    • (2006) Diabetes Care , vol.29 , pp. 2409-2414
    • Chen, H.-F.1    Ho, C.-A.2    Li, C.-Y.3
  • 24
    • 79956068772 scopus 로고    scopus 로고
    • Risk of malignant neoplasm of the pancreas in relation to diabetes: A population-based study in Taiwan
    • Chen H-F, Chen P, Li C-Y. Risk of malignant neoplasm of the pancreas in relation to diabetes: A population-based study in Taiwan. Diabetes Care. 2011; 34: 1177–1179.
    • (2011) Diabetes Care , vol.34 , pp. 1177-1179
    • Chen, H.-F.1    Chen, P.2    Li, C.-Y.3
  • 25
    • 77954237223 scopus 로고    scopus 로고
    • Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications
    • Chen HF, Chen P, Li CY. Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications. Hepatology. 2010; 52: 155–163.
    • (2010) Hepatology , vol.52 , pp. 155-163
    • Chen, H.F.1    Chen, P.2    Li, C.Y.3
  • 26
    • 77952720287 scopus 로고    scopus 로고
    • Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999–2004: A national health insurance data set study
    • Chang CH, Shau WY, Jiang YD et al. Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999–2004: A national health insurance data set study. Diabetic Medicine. 2010; 27: 636–643.
    • (2010) Diabetic Medicine , vol.27 , pp. 636-643
    • Chang, C.H.1    Shau, W.Y.2    Jiang, Y.D.3
  • 27
    • 38349102796 scopus 로고    scopus 로고
    • Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization
    • Young BA, Lin E, Von Korff M et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. The American Journal of Managed Care. 2008; 14: 15–23.
    • (2008) The American Journal of Managed Care , vol.14 , pp. 15-23
    • Young, B.A.1    Lin, E.2    Von Korff, M.3
  • 29
    • 84906794997 scopus 로고    scopus 로고
    • Risk of hospitalization and healthcare cost associated with Diabetes Complication Severity Index in Taiwan's National Health Insurance Research Database
    • Chen H-L, Hsiao F-Y. Risk of hospitalization and healthcare cost associated with Diabetes Complication Severity Index in Taiwan's National Health Insurance Research Database. Journal of Diabetes and its Complications. 2014; 28: 612–616.
    • (2014) Journal of Diabetes and its Complications , vol.28 , pp. 612-616
    • Chen, H.-L.1    Hsiao, F.-Y.2
  • 30
    • 84892649479 scopus 로고    scopus 로고
    • Standards of medical care in diabetes: 2014
    • American Diabetes Association. Standards of medical care in diabetes: 2014. Diabetes Care. 2014; 37(Suppl. 1): S14–S80.
    • (2014) Diabetes Care , vol.37 , pp. S14-S80
  • 32
    • 84866268783 scopus 로고    scopus 로고
    • Management of hyperglycemia in type 2 diabetes: A patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    • Inzucchi SE, Bergenstal RM, Buse JB et al. Management of hyperglycemia in type 2 diabetes: A patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012; 35: 1364–1379.
    • (2012) Diabetes Care , vol.35 , pp. 1364-1379
    • Inzucchi, S.E.1    Bergenstal, R.M.2    Buse, J.B.3
  • 33
    • 84934911609 scopus 로고    scopus 로고
    • Factors associated with utilization of dipeptidyl-4 inhibitors in patients with type 2 diabetes mellitus: A cross-sectional retrospective study
    • Zaman Huri H, Selamat N, Vethakkan SR. Factors associated with utilization of dipeptidyl-4 inhibitors in patients with type 2 diabetes mellitus: A cross-sectional retrospective study. International Journal of Endocrinology. 2014; 2014: 367–564.
    • (2014) International Journal of Endocrinology , vol.2014 , pp. 367-564
    • Zaman Huri, H.1    Selamat, N.2    Vethakkan, S.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.